Clinical Trials and Research
Jul 14, 2026
AbstractBackground: Sickle cell anemia is an autosomal recessive disorder caused by abnormal hemoglobin S, which polymerizes when deoxygenated and distorts…
Jul 13, 2026
AbstractAdults living with sickle cell disease (SCD) experience high rates of chronic pain, depression, and anxiety, which significantly impair quality of life.…
Jul 13, 2026
In 2010, analysis of the Dallas Newborn Cohort established a new reality for sickle cell disease (SCD): more than 90% of affected infants born after 1983 survive to…
Jul 09, 2026
AbstractChildren with sickle cell anemia (SCA) are at increased risk of cerebrovascular complications due to chronic anemia and progressive vascular injury, yet how…
Jul 09, 2026
AbstractVaso-occlusive crisis is the primary cause of morbidity and emergency department visits in patients with sickle cell disease (SCD) and may lead to acute…
Jul 09, 2026
Risk factors and outcomes of high-impact chronic pain (HICP), ie, chronic pain (CP) and substantial restriction of participation in work, social, or self-care…
Jul 08, 2026
AbstractSickle cell disease (SCD) and thalassemia are genetic disorders that necessitate accurate diagnosis for effective management and improved patient outcomes.…
Jul 05, 2026
The spleen is one of the first organs injured in sickle cell disease (SCD) [1]. Splenic impairment in SCD children can silently progress toward functional asplenia…
Jul 01, 2026
AbstractBackground and objectivesSickle cell disease is a major haemoglobin disorder, and foetal haemoglobin (HbF) remains the strongest modifier of disease…
Jul 01, 2026
AbstractImportance: Suboptimal transitions from pediatric to adult health care can negatively impact disease outcomes, medication regimen adherence, and disease…